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Various treatments have been introduced to delay or slow the progress of 
glaucoma, one of the leading causes of blindness, by reducing intraocular pressure (IOP), 
the unique manageable factor in glaucoma. However, there are limitations to the 
continuous usage of currently available treatments. A femtosecond laser presents the 
potential of advanced treatment by significantly reducing damage to tissues. This 
dissertation will address the compressive aspects of glaucoma and its treatments and the 
development of a minimally invasive surgical procedure and a supporting tool to improve 
the efficiency of this procedure. 
 xiv
The experimental setup was built to scan the eye with a femtosecond laser in a 
predetermined pattern with adjustable parameters. The outflow rate was measured before 
and after the laser treatment to evaluate the effect of the channel. It was demonstrated that 
the subsurface scleral channel that increases aqueous humor (AH) outflow rate can be 
created in ex vivo rabbit eyes with a femtosecond laser. 
Considering that the goal of glaucoma treatment is to reduce IOP into the normal 
range, a tool is required to predict the channel dimensions to achieve a predetermined 
IOP reduction. I developed a 3D finite element model and demonstrated its potential as a 
tool for estimating channel dimensions by fitting the experimental data to the model. 
 The experimental setup was altered to make a scan on an in vivo rabbit. It was 
demonstrated that the subsurface scleral channel can be created in the eyes of in vivo 
rabbits and IOP can be reduced with this channel. It was found that IOP can be reduced 
with a positive relation to the dimensions of the channel, demonstrating the potential for 
controlled IOP reduction by manipulating channel dimensions.  
Therefore, it can be concluded that the subsurface scleral AH drainage channel 
can be created with a femtosecond laser, overcoming the disadvantages of current 
treatments. The method has the potential of controlling IOP reduction with the channel 
dimensions. 3D FEM has potential as a tool for predicting the post treatment IOP and 










1.1. Chapter Outline 
Glaucoma is a progressive eye disease. Therefore, the understanding of 
fundamentals of the structure and physiology of the eye should provide the insight into 
glaucoma from cause, effect to the way it can be treated. In section 1.2, the overall 
structure of the eye, the role of each part and the mechanism of the vision is reviewed. 
Glaucoma occurs due to change in properties of some parts. Therefore, the details of 
property changes causing glaucoma and the process glaucoma can occur, progress and 
effect of the vision will be elaborated also. 
 The primary cause for glaucoma is changes in properties of some parts of the eye. 
Therefore, the glaucoma treatment is to return the changed properties to the original ones 
or make adjustment so that effects of property changes can be eliminated. In section 1.3, 
the mechanism of treating glaucoma, the way of classifying the glaucoma treatments will 
be introduced. The merits and demerits of each treatment will be also discussed providing 
the insight into the optimal treatment and how it will be developed. 
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 Lasers were introduced to the eye treatment in an effort to overcome the 
disadvantage of other treatments with very reduced and localized damage caused by this 
technology. In section 1.4, the last section of this chapter, the brief history of applying a 
laser to the surgical treatment and the fundamentals of laser tissue interaction will be 
introduced focused on the mechanisms the energy of laser beam can be deposited into the 
tissue. The history of development by introducing various lasers is provided. It will be 
also elaborated which effects each parameter has on improving the quality of treatments, 
indicating directions for future developments.  
  
1.2. Structure and Physiology of the Eye 
1.2.1. Overall Structure of the Eye 
The basic structure of the eye is shown in Figure 1.1. Entering light is refracted by 
the cornea and lens to form an image on the retina. Lens thickness is adjusted by the 
zonules to form a sharp image on the retina, which is evident at the fovea. [1]. The 
interior of the eye is composed of the anterior chamber, posterior chamber, and vitreous 
chamber, as described in Figure 1.1 and Figure 1.2.  
1.2.2.  Anterior Chamber 
As it can be seen in Figure 1.2, the anterior chamber is the space roofed by the 
cornea and floored by the lens and iris whose root is surrounded by trabecular meshwork. 
The cornea is connected to the sclera through the Schwalbe’s line, which is the limit of 
corneal endothelium. Limbus is the intermediate zone of connective tissues between 
cornea and sclera [2].  
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The cornea, the most anterior part of the eye, is the clear vascular structure 
providing a clear refractive interface, tensile strength, and protection from external 
factors [3]. The cornea is also can be modeled as a viscoelastic material when it is 
stretched and has no channel allowing bulk flow [1]. Anatomically, the cornea is 
composed of five layers, from the anterior layer, epithelium, Bowman’s membrane, 
stroma, Descemet’s membrane, and endothelium [1]. Its light transparency is from the 
stroma, an organized arrangement of collagen fibrils [4].  
The lens plays an accommodating role to make light focus on the retina [2]. It is 
composed of concentric layers defining the nucleus and cortex, with epithelial cells at the 
anterior surface and a capsule at the posterior part [5]. Lens volume is not appreciably 
affected by new fibers laid down with time, but the lens becomes harder over time and it 
becomes more difficult to accommodate the shape with zonules, leading to damage of the 
sharp image on retina [4].   
The iris controls the amount of light allowed through the lens by adjusting the 
diameter of the pupil. It adjusts its length by the contraction and dilation of posterior and 
anterior leaves using blood vessels and nerves [6]. These vessels provide the heat driving 
AH flow toward the cornea by convection.   
The sclera is a structure defining five sixths of the outer surface of the eye [7]. It 
has distinct layers, including from the inside the lamina fusca in contact with the chroid, 
scleral stroma, episclera, and Tenon’s capsule [7]. It also has a special structure on the 
posterior side called the lamina cribrosa where axons from the optic nerve exit the eye [7]. 
The sclera plays a significant role in protecting the eye and keeping optical stability with 
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its rigidity, maintaining the shape of the eye, movement of the eye, and defining the 
intraocular pressure (IOP) [7].  
1.2.3. Posterior Chamber 
The posterior chamber is the space defined by the posterior surface of the iris and 
the inner surface of the ciliary body, ciliary processes, lens, and zonules as shown in 
Figure 1.2. It is connected to the anterior chamber through the channel between the lens 
and iris. The ciliary processes is where AH is secreted as described below in the aqueous 
humor (AH) dynamics section. The zonules are composed of elastic fibers and their role 
is to stabilize and accommodate the lens. The fiber structure of zonules allows AH to 
flow into the vitreous [6]. 
1.2.4. Vitreous Chamber 
The vitreous chamber is the space filled with vitreous humor, defined by the 
posterior surface of the lens, zonules, and the retina below the ciliary body as described 
in Figure 1.1 and Figure 1.2. Approximately 80% of the eye volume is occupied by the 
vitreous chamber [6]. Vitreous humor interacts with the retina, ciliary body, lens, and 
mechanically supports the structures it contacts [5]. There are fibrils in the vitreous 
humor with collagen banding, but about 99% of vitreous mass is water [5].   
Light is detected at the retina by converting light energy into chemical energy in 
the photoreceptors [5]. Following detection, the brain recognizes the event by conveying 
the signal with bipolar and ganglion cells and finally converting it into action potentials, 
and ultimately, going down to the brain through the axon [5]. The retina is composed of 
ten layers from the outmost pigment epithelium to the inmost inner limiting membrane 
[5]. The fovea has the highest visual acuity, [1] and also has stronger pigmentation of the 
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pigment epithelium than other areas of retina, producing significant light suppression in 
this region. Photoreceptors are slender around the center of the fovea, increasing the 
density of photoreceptor. The increased number of receptors around the central fovea 
enhances visual acuity [1].  
The choroid is the layer between the sclera and the retina with the largest blood 
flow such that problems in choroidal blood vessels are related to peripheral retinal 
degeneration [1]. The choroid nourishes the retina and removes the heat produced when 
light hits the retina. In addition, the choroid cushions the interior structure of the eye [1].   
1.2.5. Aqueous Humor (AH) Dynamics 
1.2.5.1. Aqueous Humor Formation 
AH is produced from ciliary processes and exits the eye through pathways as 
described in Figure 1.2. AH maintains the refractive properties of the eye by maintaining 
IOP leading to the maintenance of cornea curvature [8]. AH also helps metabolic 
functions of avascular structures such as lens, cornea, and trabecular meshwork.  AH 
provides nutrients like glucose and amino acids and removes wastes [9].  
AH is produced from ciliary processes and secreted into the posterior chamber by 
diffusion, electrochemical gradient, and transport in exchange of chemical component 
like HCO3- , H+ and [10, 11].  AH is composed of organic substances such as ascorbate, 
glucose and inorganic substances such as biocarnate, chloride, sodium [2]. The 
components playing noticeable roles in AH secretion have different concentrations 
depending on the locations as shown in Table. 1 [10]. Especially, Na+ and Cl- have 
different concentrations between plasma inside ciliary body and anterior/posterior 
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chamber, backing up the existence of an active transport mechanism such as exchange 
pump and ion channel in the process of secreting AH into posterior chamber [10].    
   IOP is determined by AH dynamics, especially, the balance between inflow and 
outflow of AH to the anterior chamber. While circadian change of IOP is by the 
fluctuation of AH inflow [12], the elevation of IOP leading to glaucoma is by the 
alteration in the resistance of AH flow along outflow pathway [13]. Produced by ciliary 
processes, AH flows into the anterior chamber through the channel between the lens and 
the iris and exits the eye through two routes, trabecular (conventional) and uveoscleral 
(unconventional) pathways.  
1.2.5.2. Trabecular (Conventional) Pathway 
As it can be seen in Figure 1.3 and Figure 1.4, following the trabecular pathway, 
AH exits the eye through trabcular meshwork, Schlemm’s canal, collector’s channel, and 
to episcleral vein, its final destination of AH. The trabecular meshwork is composed of 
the uveal meshwork, corneoscleral meshwork, and juxtacanalicular meshwork [9]. Uveal 
meshwork has the porous structure with 25 – 75 µm diameter [14]. The diameter is 
reduced to be 2 – 15 µm in the deep layer of the corneoscleral meshwork [14]. It was 
proven experimentally that both of uveal and corneoscleral meshwork have ignorable 
outflow resistance [15].  
The Juxtacanalicular meshwork (JCT) with 2–15 µm thickness [16] and 30–40% 
open space [14] is located between the corneoscleral meshwork and the Schlemms’ canal, 
so that the inner endothelial layer is in contact with the corneoscleral meshwork and the 
outmost portion with inner wall of the Schlemm’s canal [9]. JCT has been believed to be 
the source of majority of AH outflow resistance [16]. The Schlemm’s canal is defined as 
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the space between the outer portions of juxtacanalicular meshwork composed of 
endothelial cells layer and the sclera [9]. The schlemm’s canal is open at low IOP, but 
collapsed by the expanded trabecular meshwork at high IOP. The outflow resistance of 
canal at low IOP should be ignorable [18], but it is theoretically possible that the 
collapsed canal can provide the increased outflow resistance. However, it was found that 
IOP of non-glaucomatous eye can’t be increased as high as glaucomatous eye by 
collapsing of the Schlemm’s canal only [19, 20], leading to the conclusion that the 
collapse of Schlemm’s canal can not cause glaucoma. Flowing out of Schlemm’s canal, 
AH flows into the episcleral vein through collector’s channel and the aqueous vein with 
tens of micrometer diameters [21]. It was demonstrated the outflow resistance in both are 
proved to be negligible [22] and it is supported by the experiments that the laser 
trabeculoplasty (LTP) acted on trabecular meshwork successfully reduced outflow 
resistance [23, 24]. Therefore, it can be concluded based on the studies that the most 
efficient way to reduce the outflow resistance along the trabecular pathway is to remove 
JCT. However, it should be very difficult to remove only the layer with 2–15 µm 
thickness inside the sclera. 
1.2.5.3. Uveoscleral (Unconventiaonal) Pathway 
As is described in Figure 1.2 and Figure 1.3, AH enters the uveoscleral pathway 
through ciliary muscle, flows across the ciliary body and exits through the supraciliary 
space and across the anterior or posterior sclera. Even though it has been known that the 
uveoscleral pathway accounts for some of the total outflow rate, the treatment over the 
uveoscleral pathway to increase outflow rate has been considered to be not as efficient as 
the one over the trabecular pathway for physiological and practical reasons. 
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1.2.5.4. The Treatment for the Management of IOP 
The amount of the outflow the uveoscleral pathway account for is so different in 
each species that it accounts for 80 % in mice, 60% in monkies and 8% in rabbits [3]. 
Therefore, the expanded Goldmann equation is used to calculate the uveoscleral outflow 
rate [25].    
F = Fs + Fi = (Pi – Pe) / Rs + Fi 
F: the AH flow rate into and out of the anterior chamber 
Fs: the trabecular (pressure-sensitve) AH outflow rate  
Fi: the uveoscleral (pressure-independent) AH outflow rate 
Pi: IOP, Pe: the pressure of episcleral vein (extraocular recipient) 
Rs: the resistance of trabecular AH outflow 
It can be seen in the equation that the uveoscleral outflow rate is calculated using 
other measurements. However, the trabecular outflow is pressure-sensitive [26] and there 
is the possible introduction of errors in using the expanded Goldmann equations, 
indicating the basic information for the treatment can’t be provided. It can be seen in 
Figure 1.5 that the uveoscleral outflow rate is not pressure-insensitive and the 
contribution to the management of IOP will be reduced at high IOP [3], leading to the 
reduced impact of the uveoscleral treatment on the reduction of IOP. As it can be seen in 
the Figure 1.3, AH exits the eye over the much larger scleral surface along the 
uveoscleral pathway, indicating that the treatment should be conducted over the larger 
surface. There is also not enough information on the outflow resistance distribution along 
the uveoscleral pathway. In the case of the trabecular pathway, the distribution of the 
resistance along the trabecular pathway has been known that JCT has the highest 
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resistance. Therefore, the optimal treatment can not be achieved over the uveoscleral 
pathway. In addition to this, there is the possible damage to the components such as 
choroid and ciliary body around the uveoscleral pathway. 
 Based on these reasons, it can be concluded that the treatment should be given 
over the trabecular pathway. Therefore, treatments will be introduced focused on this area. 
 
1.3. Glaucoma and its Treatment 
Glaucoma is a progressive optic nerve disease causing the selective loss of nerve 
fibers [27] leading to the visual field loss [27, 28] and its source and progress are 
different based on kind of glaucoma to be described later. Glaucoma is the second 
leading cause of blindness in the world [27] and 130,540 people lost sight from primary 
glaucoma in 2000 [29] and there are 300,000 new cases of glaucoma every year in US 
[30]. Looking at these studies, the effects of glaucoma associated visual loss on the 
economic and daily life such as treatment cost and accidents [31-38] can be estimated and 
the significance of effective glaucoma treatment can be recognized easily.  
There are various kinds of glaucoma such as developmental glaucoma including 
congenital glaucoma caused by abnormal development like the root of the iris covering 
the surface of trabecular meshwork [9] and the secondary glaucoma caused by abnormal 
ocular and systemic conditions like new blood vessels covering the trabecular meshwork 
[39]. However, primary glaucoma, primary open angle glaucoma (POAG) and primary 
angle closure glaucoma (PACG), has been known to account for the majority of 
glaucoma occurring to people in the world. The review of the World Health Organization 
(WHO) showed that the cases of newly diagnosed POAG is estimated to be 2,400,000 per 
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year [40] and 3,000,000, out of 5,000,000 people who lost vision from glaucoma, became 
blind from POAG [41]. PACG is more frequent in Asia [42]. Therefore, in this section, 
the details of primary glaucoma will be introduced putting emphasis on POAG, more 
prevalent over the world. 
1.3.1. Primary Open Angle Glaucoma (POAG)  
1.3.1.1. Definition 
The diagnostic criteria for POAG used in many studies are the optic nerve head 
and visual field damage [43, 44]. However, following the definition by the 1996 
American Academy of Ophthalmology Preferred Practice Pattern, POAG is chronic, 
generally bilateral, often an asymmetrical disease with characterizing factors, 
glaucomatous optic nerve damage, adult onset, open, normal-appearing anterior chamber 
angles, and absence of known other causes of open angle glaucoma [45].  
1.3.1.2. Risk Factors  
It has been shown that the risk of POAG is increased over age [46] and the 
prevalence of POAG in specific races [46, 47], family with glaucoma history [47, 48] and 
elevated IOP [12]. However, IOP has been considered to be the most significant factor 
among others, because IOP is the uniquely treatable one. It has been believed in POAG 
that IOP is elevated by reduced AH outflow rate originating from the increased outflow 
resistance along the pathways [48] in possible association with decreased endothelial cell 
number [49] with thicker basement membrane [50, 51] and trabecular meshwork cells 
lost over age [52]. Various treatments that can be classified into medical, surgical, and 
laser treatment have been introduced to reduce IOP by reducing the production of AH or, 
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in most cases, the AH outflow rate resistance ultimately leading to the increased AH 
outflow rate. 
1.3.1.3. Treatment of POAG 
1.3.1.3.1. Medical (Drug) Treatment 
Drugs have been used to lower IOP in various forms such as drop, aqueous 
solutions, ocular inserts and gels [52]. Considering AH dynamics that IOP is decided by 
the balance between the AH inflow and outflow of anterior chamber, theoretically, IOP 
can be reduced in two ways, increasing AH outflow and reducing AH production. For the 
case that the abnormally large amount of AH is secreted, medications can be selected to 
reduce the amount of AH secretion by interfering the AH production process described in 
the section of structure and physiology of the eye. For example, the enzyme carbonic 
anhydrate (CA), especially CA-ІІ, was found to be present in nonpigmented epithelium of 
the ciliary processes supporting carbonic anhydrate’s role in the transfer of sodium 
bicarbonate and fluid into AH [53]. Based on this discovery, carbonic anhydrate 
inhibitors (CAI) such as acetazolamide, methazolamide and ethoxzolamide have been 
used to reduce AH formation by interfering AH production process [53]. However, in 
most cases, medical treatment works the other way, because IOP is elevated in 
glaucomatous eyes by reducing the AH outflow and it should be more efficient to treat 
glaucoma by reducing the AH outflow resistance. For example, cholinergic agents such 
as pilocarpine and acecline widen the spaces in trabecular meshwork and the Schlemm’s 
canal by stimulating the muscle of ciliary body to contract [9, 54], leading to the reduced 
AH resistance.  
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However, medical treatment has unavoidable disadvantages such as adhesion and 
tolerance from continuous usage over time, cost from effect reduced over time, and 
various side effects [9]. For example, CAIs have ocular side effects such as supraihroidal 
effusion, surface irritation, dryness, [9] systemic side effects such as anorexia, weight 
loss, and fatigue [9]. Cholinergic agents also have ocular side effects such as degraded 
vision by miosis, severe headache from muscle spasm, and accommodative myopia [9]. It 
is also hard to significantly reduce IOP and control the amount of reduced IOP with 
medical treatment. 
1.3.1.3.2. Surgical Treatment  
Surgical treatments for OPAG can be classified into three operations depending 
on the detailed approach [30]. Even though there is AH production reducing operation in 
surgical treatment, the majority of surgical treatment is AH outflow increasing operation. 
Operations to improve extraordinary drainage of aqueous humor 
It can be divided into the operation with a scleral flap such as trabeculectomy and without 
a scleral flap such as sclerectomy [30]. A trabeculectomy described in Figure 1.6 (a) is 
the operation to increase AH outflow by creating a partial-thickness flap of the sclera 
covering the opening between the anterior chamber and the subconjunctiva space to 
overcome the complications of full thickness operations [30].  The overall process is 
composed of dissecting a scleral flap, excising Schlemm’s canal, and trabecular 
meshwork and suturing the flap [55]. Sclerectomy, described in Figure 1.6 (b), is to 
create the opening from anterior chamber to the conjunctival flap whole through the 
sclera [56]. Sclerectomy is used when visual loss is very severe and IOP should be 
reduced significantly to stop the progress of visual loss [56].   
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Operations to form paths for intraocular drainage of aqueous humor such as 
goniotomy  
Goniotomy is to make the direct access to the Schlemm’s canal by removing the tissues 
blocking the AH flow through the Schlemm’s canal with a fine knife by incising the 
anterior chamber [30, 9]. 
Operations to reduce production of aqueous humor such as cyclodialysis 
Cyclodialysis is to create the direct AH outflow communication between the anterior 
chamber and suprachoroidal space by separating ciliary body from a scleral spur [30]. 
The communication is created by inserting the tip of a spatula into the anterior chamber 
through the suprachoroidal and widening it by sweeping the spatula as shown in Figure 
1.7 Cyclodialysis has disadvantages such as hemorrhage in the anterior chamber and 
stripping of the Descemete’s membrane [30].  
Surgical treatment is used especially when medical treatment does not work well, 
the amount of needed IOP reduction is too large, and the control over the amount of 
reduced IOP is needed. However, surgical treatment has disadvantages such as scar, 
bleeding, infection, and the structural damage to the eye from its unavoidable incisional 
procedures [12].   
1.3.1.3.3. Laser Treatment 
Laser Trabeculoplasty (LT) is more widely used POAG laser treatment. LT 
decreases outflow resistance by thermally burning the surface of trabecular meshwork as 
shown in Figure 1.8, causing the loss of endothelial cells, disruption, scaring, and 
shrinkage of the trabecular beam leading to the adjacent opening of pore by tension [9]. 
LT also causes the AH outflow resistance reducing biochemical response of treated 
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trebecular meshwork tissues [12]. The most widely used types of LT are argon laser 
trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT) with Q switched 
frequency-doubled Nd:YAG laser. 
ALT is advantageous in that it has much reduced compliance, side effect issue, 
and it is effective as initial therapy to reduce IOP such that 63% of patients maintained 
IOP control 1 year after ALT [57, 58]. However, the continuous use of ALT is limited by 
mass destruction of the cell and the trabecular beams around the treated area [9]. ALT 
also has disadvantages such as unsatisfactory long-term effect and the possible failure 
because trabecular meshwork (TM) is partially burned [9].  
SLT works using the same mechanism as introduced in the ALT mechanism. The use of 
SLT is advantageous over ALT since SLT has a greater IOP reducing effect than the 
ALT retreatment in patients with ALT failure [9]. SLT is also advantageous since it 
reduces tissue destruction when compared to ALT. This can be explained with  more 
confined heat deposition to the tissue due to the much shorter pulse used in SLT [9], 
proposing the potential of more advantageous laser treatments by the continuous 
reduction of pulse duration into shorter regime. 
1.3.2. Primary Angle Closure Glaucoma (PACG) 
1.3.2.1. Definition 
PACG is defined as “appositional or synechial closure of the anterior chamber 
angle closed by relative pupillary block in the absence of other causes of angle closure” 
[45]. The most common way that PACG occurs is when AH flow to the anterior chamber 
from the posterior chamber is blocked by the apposition of the iris pupil against the lens, 
leading to a pressure increase in the posterior chamber [9]. Then, the peripheral iris will 
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be pushed upward, called iris bombe described in Figure 1.9 (a), and the AH flow into 
trabecular meshwork is reduced. If the peripheral iris keeps pushed, AH outflow into 
trabecular meshwork (TM) can be blocked by the iris as shown in Figure 1.9 (b). The 
increased IOP is dependent on the area of TM covered by the iris. IOP can be increased 
from 20 to 40 IOP when the entire TM is covered [9]. 
1.3.2.2. Risk Factors 
Shallow anterior chamber, short axial length, and small corneal diameters are well 
known risk factors, but the shallow anterior chamber is the most consistent factor [60]. A 
shallow anterior chamber is inherited, related to age, gender, and race [55, 60]. The 
prevalence of PACG is 4 – 5 times higher in women [60] and 3.5 – 6 times in Inuit with 
the first degree relatives of affected parents and in family members of affected Chinese 
parents [61]. 
1.3.2.3. Treatment of PACG 
1.3.2.3.1. Medical (Drug) Treatment 
Additionally to lowering IOP, medical treatment for PACG includes clearing the 
cornea to make a laser treatment and laser iridotomy available [9]. Medical treatment is 
composed of beta-adrenergic blocking agents and topical carbonic anhydrase inhibitors 
(CAI) [9]. For example, 1 or 2% of the pilocarpine, can be used to open the angle and 
stretch the iris to make the iridotomy available [9].   
1.3.2.3.2. Surgical Treatment 
Iridectomy is the act of excising a piece of the iris to deepen the anterior chamber 
and is the most frequently used surgical treatment for pupillary block, especially when 
laser iridectomy is not available due to poorly visible iris from the opaque cornea or 
 15
occlusion from intraocular inflammation [56]. The key process is to create the opening 
through the limbus, undermining conjunctiva [56]. 
1.3.2.3.3. Laser Treatment 
Laser iridotomy is the process that creates a thick hole in the iris as shown in 
Figure 1.10. A hole can be created with surgical procedure, called iridectomy before the 
laser was introduced. However, an iridectomy has many complications such as infection 
and would leak from the incisional penetration of surgical tools [9]. The argon laser was 
introduced first to create a whole, but the Nd:YAG laser is preferred because of its 
advantage of property without the disadvantages of the argon laser such as coagulative 
effect in the adjacent stroma [9].  
A Gonioplasty (GPL) is performed to widen the angle with contraction of the iris 
by heating the iris tissue neighboring the root of the iris [30]. When the heat is applied to 
the iris tissue by a laser, the tissues around the heated spot are contracted. If the tissues 
near the root of the iris are heated, the tissues at the iris root move deeper from the 
contractions [30]. If the tissues near the end of iris are heated, the pupillary block can be 
opened by the contraction [62, 63]. This treatment can be used as a supporting treatment 
for other ones such as laser a trabeculoplasty and a laser iridotomy [30]. However, GPL 
has disadvantages such as the potential of immediate postoperative IOP spike, distortion 
of the pupil, and possible heat of the endothelium in the eye of the shallow anterior 
chamber [30]. It is difficult to control the amount of IOP reduction also.  
 Taking a look at the glaucoma treatments that have been developed, it can be seen 
that the history of developing treatments is the process to achieve the treatment with 
advantages of medical and surgical treatments, nonincisional and controllable one. As 
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lasers showed the potential of this treatment, various lasers with the better properties of 
the interaction with tissues have been introduced in different methods over the 
development of lasers. As the new laser with reduced pulse duration was recently 
introduced with the advantageous property, the attention has been drawn to the 
development of methods that can make advantage of this laser for the eye treatment. In 
the next chapter, the details of that laser, called a femtosecond laser, will be introduced. 
 
1.4. Laser Tissue Interaction 
Since the potential of the laser microsurgery was proposed by the dissection of 
chromosome with an argon laser [64, 65], the development of laser treatment has been 
led by the advance of laser technology. The range of available laser parameters in laser 
tissue experiments was expanded by laser technology development, thus the mechanism 
of laser energy deposition into the tissue, and the effect of each laser on it could be 
investigated [66 - 68] with a wide range of pulse durations. It was found that the pulsed 
laser has more advantageous interaction property with tissue than the continuous wave 
laser and the major improvement on the laser tissue interaction could be made by 
reducing the pulse duration that can make more precise treatment available [69]  
The eye treatment has been the major application field of the microsurgery by a 
laser, because the extreme precision is needed that can never be achieved by traditional 
surgical techniques. Additionally, traditional surgical treatment has the limitation of using 
unavoidable incisional procedures performed with surgical blades that can cause bleeding, 
scar [30]. Argon laser has been widely used, but lasers with more advantageous 
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interaction with tissues, such as Nd:YAG laser [70], were introduced to perform more 
advanced treatments. 
In this section, the fundamentals of the laser tissue interaction will be discussed, 
Initially laser-tissue interaction mechanisms of argon laser and Nd:YAG laser will be 
compared. Then, the femtosecond laser, which came into the spotlight with the potential 
of alternative laser for more advantageous treatments, will be introduced. 
1.4.1. Deposition of Laser Energy into the Tissue 
1.4.1.1. Linear Absorption 
In the case of linear absorption the photon energy of the laser is in resonance with 
the electron excitation energy of the molecules in the tissue. Thus, if the laser beam 
irradiates the tissue, the absorption of the photon promotes the level of electrons to the 
excitation level [72]. Then, collisions of electrons and nonradiative relaxation convert 
this energy into the heat, leading to temperature increase in the tissue [70]. In the 
wavelength of ultraviolet (UV) and near infrared (NI) region (λ ≈ 780 – 2500 nm), 
melanin and hemoglobin are strong and dominant absorbing molecules in ocular tissues 
and thermal effect are dependent on the responses of these molecules to a laser beam [72, 
73].  
The extent of thermal tissue damage is dependent on the temperature increase. No 
irreversible damage occurs up to 45 oC, tissue temperature, and denaturation of 
biomolecules, coagualation effect, occurs from 60 oC [70]. The extent of effect is 
proportional to irradiation time and power of laser beam in photocoagulation, the 
working mechanism in ALT and SLT. The laser parameters are λ = 488 to 514 nm, 0.1 s 
irradiation time for ALT and λ = 532 nm, 3 ns pulse duration for SLT [71]. Comparing 
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the irradiation time of each one to 1µs [74], the thermal relaxation time of melanin, it can 
be seen that SLT with shorter duration than the thermal relaxation time, should have 
much reduced effect on the tissues adjacent to the treated spot.  
1.4.1.2. Nonlinear Absorption 
1.4.1.2.1. Definition and Free Electron Generation 
In the case of nonlinear absorption the energy of the laser photons are smaller 
than the differences of the electron energy levels. Thus, the absorption of multiple 
electrons occurs simultaneously to achieve excited state. This requires high electron 
density therefore nonlinear absorption usually occurs when the irradiance of the laser 
beam is higher than 1010 ~ 1013 W/cm2 [72]. If electrons absorb energy higher than the 
ionization potential, the medium is ionized and free electrons are generated. Free 
electrons can be generated by the one of the following ionization mechanisms in tissue as 
described in Figure 1.11 [72, 75]. 
Multiphoton Ionization 
In the case of Multiphoton ionization free electrons are created with the absorption of 
several photons simultaneously [72]. Therefore, it does not take much time and space to 
generate free electrons via multiphoton ionization and seed electron, existing free 
electron, is not needed.  
Avalnche Ionization 
At least one free electron, a seed electron, is needed for avalanche ionization. Free 
electrons absorb the laser beam energy and this energy is converted into the kinetic 
energy. If the kinetic energy of electron is increased high enough, free electrons can be 
generated by the collision between free electrons and molecules. 
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1.4.1.2.2. Laser Induced Optical Breakdown (LIOB) 
Increased intensity and radiant time lead to the increase of free electrons density 
by the combination of ionization processes mentioned in the previous section. If the 
density of free electrons reaches 1021/cm3 plasma is formed and this process is called 
optical breakdown [72]. This laser induced optical breakdown (LIOB) initiates 
photodisruption, the phenomenon that the tissue is disrupted by the high-power ionizing 
laser pulses [76].  
Once plasma is formed, the kinetic energy of free electrons is converted into the 
temperature and pressure increase by the collisions with other molecules. As described in 
Figure 1.12 [66], the plasma is expanded by increased pressure and temperature, leading 
to the tension stress on the material by the expanding the plasma [77]. The shock wave is 
emitted when the velocity of the plasma expansion is reduced to the subsonic from the 
initial hypersonic velocity [78]. When the liquid is ruptured by the tensile stress under the 
isothermal condition, it is called ‘cavitation’ [69]. Bubbles are created and imploded 
when the plasma is continuously expanded [76, 79] and these bubbles are called 
‘cavitation bubbles’ and used as criteria of the occurrence of photodisruption [69]. Shock 
wave and cavitation bubbles contribute to the disruption effect of a laser, but, as 
described in Figure 1.12 [66], their effects are on the space plasma expansion, reducing 
the precision of laser treatment [80]. Therefore, it can be concluded that the evaporation 
of plasma is the main effect for photodisruption and shock wave and cavitation bubble 
are considered to be the unwanted side effects [80]. 
1.4.1.2.3. The Effect of Pulse Duration on Photodisruption 
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The wider range of laser parameters could become available over the 
development of laser technology. It was found that the pulse duration is the laser 
parameter with the effects on the property of the deposition of laser beam energy into the 
tissue [80]. The effect of the pulse duration on the laser tissue interaction can be 
explained along the photodisruption process.   
Ionization Processes 
As the pulse duration is reduced, the contribution of avalanche ionization to LIOB is 
reduced due to the lack of time to absorb and converse the beam energy into the kinetic 
energy of electrons, followed by collisions with other electrons, molecules [75]. 
Therefore, the contribution by the multiphoton ionization is increased to LIOB over the 
reduced pulse duration, leading to the change in other properties of laser tissue interaction 
to be explained later. 
More Consistent Electron Density in Plasma  
An existence of seed electron, basic necessity of avalanche ionization, is dependent on 
the molecular structure, especially impurities, of the irradiated material [70] and the 
collisions between molecules and electrons cannot be controlled. On the contrary, 
multiphoton ionization is not affected by seed electrons. Therefore, the density of free 
electrons in plasma can be maintained more consistently by reducing the pulse duration. 
Reduced LIOB Threshold  
Irradiance threshold (W/cm2) for LIOB is increased as the pulsed duration is reduced, 
because, as explained in ‘ionization process’ section, the contribution by avalanche 
ionization to the plasma formation is reduced. However, as shown in Figure 1.13 [81], the 
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energy threshold is reduced over the shorter pulse duration, because there is no time for 
the recombination of free electrons during the short pulse duration [69]. 
Reduced Side Effects  
Figure 1.14 [81] shows the shock wave pressure over the radius in water generated by 
lasers with different duration, 150 fs and 60 ps [81]. It can be seen that shock wave 
pressure is reduced rapidly when it is generated by 150 fs laser, meaning the rapid 
reduction of the shock wave propagation velocity. Therefore, it can be concluded that the 
space under the effect of shock wave is reduced with shorter pulse duration of a laser.  
Cavitation bubble is generated, expanded while the plasma is expanded. As the 
pulse duration is reduced, the plasma expansion time is also reduced. Therefore, 
cavitation bubble is expanded for the shorter period, leading to the reduced diameter of 
cavitation bubble [81].  It was shown that when measured 1 ms after the irradiation of a 
laser in corneal tissue, the diameter of cavitation bubble is 14 μm by femtosecond pulses 
and 80 μm by picosecond pulses [79]. 
Confined Treatment 
If the pulse duration is reduced into the femtosecond regime, temperature is elevated 
within a few to tens of picosecond much shorter than 1 µs, the heat relaxation time for 
melanin [30, 72], indicating the thermoelastic stress is confined in the focal volume [30]. 
Adding this effect to the reduced side effect, the confined effect of the short duration 
pulse can be easily expected [69], indicating the potential of more precise surgery of 
femtosecond pulse lasers. 
1.4.2. Optical Penetration Depending on the Wavelength of the Pulse 
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As it was mentioned, lasers were introduced to the eye treatment to develop the 
noninvasive treatments. To make advantage of this beauty of laser treatments, subsurface 
laser treatment should be available without any damage to the surface of tissue and laser 
beam should penetrate and be focused into the tissue deep enough to treat the target area 
below the surface. When laser beam is irradiated to the tissue, the following five 
phenomena can occur [9];  
1) Reflection: when laser beam is reflected backward at the surface of tissue in the small 
portion. 
2) Refraction: when laser beam passes, being refracted, through the surface, it is affected 
by the incidence angle and the refractive index difference between two media of air 
(1.0) and sclera (1.37).  
3) Absorption: when energy of beam is absorbed by the molecules depending on the 
absorbing coefficient in the function of wavelength, indicating the absorption can be 
minimized by selecting the proper wavelength.  
4) Scattering: bend of light wave propagation when the traversing wave is faced to the 
local change of the media. 
5) Traverse through tissue: the photons passing through the tissue in the propagating 
direction of the beam.  
Small portion of a beam is reflected and refraction can be reduced by introducing 
the glass and adjusting the penetration angle of beam into the tissue. Therefore, it can be 
concluded that photons are affected in the irradiance by absorption and in focus beyond 
the tissue by scattering. Refractive index and the micro structure inside the material have 
the effect on scattering and it is difficult to predict the scattering by the calculation. 
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However, it has been known that scattering is decreased over wide range of wavelength, 
as the wavelength is increased [70] and the absorption of photons is affected by 
wavelength [73] and near infrared laser beam with wavelength from 780 nm to 2.5 µm 
[70] can penetrate deep into the biological tissues due to its low absorption and scattering 
coefficients inside the biological tissues [82]. Therefore, it should be the best approach to 
select the wavelength of laser beam experimentally by investigating the penetration depth 
and focus into or beyond the target tissue over the near infrared wavelength.      
1.4.3. Selecting the Optimal Laser Parameters for the Treatment of the Eye 
The optimal wavelength should be selected for each laser treatment, because the 
absorption and scattering property of each tissue is different depending on wavelength. 
The scattering through sclera was investigated by monitoring the focus over near infrared 
wavelength [83]. Figure 1.15 shows that the wavelength to minimize the scattering is 
1700 nm [83].  
The absorption of a laser beam was investigated over wavelength as shown in 
Figure 1.16 [85]. It can be seen that there are three peak points of transmission and the 
one of them is 1700 nm, indicating the absorption is minimum at those wavelengths. 
Combining the results shown in Figure 1.15 and Figure 1.16, it can be concluded that 1.7 
µm is the optimal wavelength of a laser beam for the eye treatment that minimize the 






Figure 1.1. Overall structure of the eye (P.P:  Posterior Pole, A.P: Anterior Pole, VA: Visual 
Axis) [2]. Light forms image on retina through cornea and lens. Each structure adjusts the 












Figure 1.2. The structure of the parts involved in AH flow [26]. AH is secreted from ciliary 
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Cl  109 134 
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Figure 1.4. Components of trabecular meshwork [6]. AH flows through uveal, corneoscleral 
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Figure 1.7. Operation of cyclodialysis ((a) Insertion of a spatula, (b) Widening the 




















Figure 1.8. Location of laser burns in ALT and SLT (A: junction of pigmented and 
nonpigmented TM, AA: completely in the nonpigmented meshwork, P: completely in the 

































Figure 1.9. PACG cased by iris bombe and blocked TM ((a) PACG by iris bombe, (b) Light 






















































Figure 1.11. Schematic of (a) Avalanche ionization by the collision and (b) Multiphoton 




























(a) 25 ps 
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Figure 1.12. The description of shock wave and cavitation bubble generation process over time 
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Figure 1.13. LIOB threshold over pulse duration on the surface of various materials ((a) Human 
enamel, (b) Human corneal tissue, (c) Bovine brain tissue) [81].  
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Figure 1.14. Shock-wave pressure as a function of the shock-wave radius in water generated by 































Figure 1.15. Focus beyond the sclera over wavelength [83]. Each side of red square at right 



































Figure 1.16. Transmission over wavelength [84]. Magnitude of transmission is different in each 
treatment of sclera before the measurement, but the scattering is dependent on wavelength 
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OUTFLOW RATE INCREASE BY A FEMTOSECOND LASER CREATED 




As it was explained in glaucoma treatment section of Chapter 1, the advantage of 
the laser treatment is its incision free operation avoiding the structural damage and 
infection caused from scar and bleeding. However, compared to the surgical treatments 
creating extraordinary aqueous humor drainage, it can be expected that laser 
trabeculoplasty, which creates fine pores and induces biochemical change by thermal 
burning, would not have as much IOP reducing effect as the surgical treatments [1, 2]. In 
addition to this, it can be expected that thermal burns will be healed much quicker, 
leading to the limitation of longevity of laser treatment. Therefore, it should be a more 
complete treatment to create drainage channel by a laser without any incisional procedure, 
achieving the advantage of both treatments.  
However, laser treatments could not be developed to create drainage channel due 
to the following technical difficulties; first, tissues should be disrupted with the minimal 
damage to the surrounding tissues. The multiple and intensive treatment by a high 
intensity laser over target space are needed to create channel, indicating the unavoidable
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damage to tissues neighboring target space. Second, a laser beam should be focused 
beyond the target tissue. Drainage channel should be created from the posterior surface of 
sclera, especially trabecular meshwork, indicating the need of focusing a laser beam 
beyond the sclera. Third, the procedure to create the drainage channel should be 
developed. It takes a stronger treatment over the wider range of tissue to create the 
channel by the continuous disruption of tissues. 
Recent studies proposed the potential of a femtosecond laser as an alternative to 
create the channel, making advantage of the changes in the properties of interaction with 
tissues over the reduction of pulse duration described in Chapter. 1. It was found that 
when the pulse duration is reduced to the femtosecond regime, the confined disruption of 
tissue can be obtained [3 - 5]. It was shown that a 1.7 µm wavelength tuned laser beam 
can be focused beyond the sclera, avoiding the big loss in energy while traversing the 
tissue [6]. It was also demonstrated that the transscleral channel can be created by 
scanning in a rectangular raster pattern from the posterior surface of the sclera [7].  
In this chapter, the laser system to deliver a femtosecond laser will be introduced, 
followed by the experimental setup to mount the eye for the outflow measurement and 
the scanning. The outflow rate measurement setup to demonstrate the effect of drainage 
channel will be introduced also. Then, it will be described how the scanning was 
performed to create the designated pattern with predetermined parameters. Finally, the 
image of the channel and results of the outflow rate change measurements will be 
provided. These measurements demonstrate the efficiency of the subsurface partial 
thickness scleral channel created in cadaver rabbit eyes to increase the outflow rate, 
potentially leading to the reduction of IOP in the eyes of in vivo rabbits.  
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2.2. Methods 
2.2.1. Experimental Setup 
Laser and Beam Delivery System                    
The Ti:Sapphire laser system was composed of oscillator, pulse stretcher, regenerative 
amplifier, pulse compressor and optical parametric amplifier (Coherent; Santa Clara, CA) 
and arranged as shown in Figure 2.1. LabVIEW (National Instruments, Austin, TX) was 
used to develop the software to control the lasers. Amplified pulses with durations of 
130-fs and pulse energies greater than 0.3 mJ were produced by the system at 
approximately 800 nm wavelength and 5 kHz repetition rate. The pulses from 
Ti:Sapphire laser system were tuned to 1.7 µm wavelength, by an optical parametric 
amplifier (Coherent; Santa Clara, CA). Output laser beam from optical parametric 
amplifier was expanded through beam expander, reflected by mirrors and focused to 5 
µm diameter spot through 0.5 NA aspheric lens (Thorlabs; Newton, NJ)       
Scanning Setup 
A schematic view of the scanning mechanism is presented in Figure 2.2. The laser beam 
was focused into the tissue using a 0.5 NA focusing lens. The enucleated eyes were 
placed on a three-axis scanner stage driven by three stepper motors, one along each axis 
as described in Figure 2.3 (Newport MM1000 and stepper motors; Newport Corp., Irvine, 
CA). The stepper motors were controlled by a computer using LabVIEW 7.1 (National 
Instruments, Austin, TX) through electronic controller (ESP 300, Newport Corp., Irvine, 
CA). The axis parallel to the propagation of the light is referred to as the Z-axis. The X-
axis is tangential to the corneal perimeter and the Y-axis is perpendicular to the XZ plane. 
As a result, the three scanning axes compose a Cartesian coordinate system. In order to 
 50
minimize light scattering on the surface of the tissue a microscope slide was placed on 
the cadaver eye at the proposed location of the channel. The scanner stages were moved 
along programmed patterns with predetermined parameters to create the partial thickness 
AH drainage channel in the sclera. 
Outflow Rate Measurements  
Standard perfusion experiments were performed in cadaver rabbit eyes to demonstrate the 
effect of subsurface partial thickness scleral channel created by the femtosecond laser and 
investigate the effect of channel dimensions on the extent of the channel effect. Figure 
2.4 displays the schematics of the aqueous humor outflow measurement setup modified 
from the one developed by Brubaker [8]. The reservoir containing balanced salt solution 
(BSS) was connected to the enucleated rabbit eye.  A 23 gauge needle with an opening 5 
mm from the tip was inserted into the eye in the holder so that the tip was located in the 
posterior chamber and the hole in anterior chamber, to prevent the deepening of anterior 
chamber. The position of needle and eye in the holder was fixed in gypsum. The surface 
of eye was covered with wet paper to prevent dehydration. A valve was introduced 
between needle and tube to detach and reattach the eye to the outflow measurement setup 
for the laser treatment. The intraocular pressure (IOP) was controlled by adjusting the 
height difference between the surface of the liquid in reservoir and the tip of needle. The 
mass of liquid in reservoir was measured periodically by a micro scale connected 
electronically to a computer using LabVIEW 7.1 (National Instruments, Austin, TX).  
2.2.2. Experimental Procedures 
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Enucleated rabbit eyes no older than 48 hours postmortem were used in the 
studies. As the first step, aqueous outflow rate was established in an untreated eye. This 
step is referred to as the baseline measurement and was conducted in the following order:  
1. The perfusion needle was inserted into the eye as the above described procedure 
and position, preventing the introduction of bubble into the anterior chamber. 
Then the eye and the needle were incased in gypsum. 
2. The flow was started by opening the valve between the reservoir and the eye, and 
the flow rate was stabilized by leaving the eye setup intact for 30 minutes at 10 
mmHg perfusion pressure. 
3. The perfusion pressure, also the IOP in this setup, was set to 15 mmHg by 
adjusting the height difference between the surface of solution in reservoir and the 
eye globe. 
4. The change of mass of the reservoir was measured every 5 second for 10 minutes 
by the micro scale connected to the computer.  
5. Steps 3, 4 were repeated at 25mmHg perfusion pressure. 
Flow rates were measured in the unit of mass/time and converted into 
volume/time (µl/min) by taking into account of the density of the BSS solution in the 
reservoir. The flow rate was selected as the steady state outflow rate that kept same value 
for at least 2 min. The valve was closed after the baseline measurement, and the eye and 
needle contained in the holder were detached from the outflow measurement setup.  
A microscope slide was placed on the globe at the position where the channel 
needed to be created, and the eye was placed on the scanner stage. Laser pulse energy 
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was set to 17µJ. To determine the zero depth (reference point for the scanning in the Z 
direction), the focal point of laser beam was adjusted to the bottom surface of the 
applanation glass (anterior scleral surface). Before starting the scanning process the focal 
point of the laser was moved into sclera, so that the optical breakdown occurred at or 
below the posterior scleral surface. Scanning parameters were set to be a 3 µm spot 
separation, a 5 µm line separation and a 2 µm layer separation. Spot separation was set by 
adjusting the scanning velocity along X axis and line, layer separations were entered into 
LabVIEW program as an input. As shown in Figure 2.2, scanning along X and Y axis is 
made on the surface normal to the direction of beam propagation.  
As described in Figure 2.5, the focal point of the laser was scanned along a raster 
pattern so that the focus of the laser is moved parallel to the width of the channel by the 
spot separation (a predetermined channel dimension), and moved, by a line separation, 
normal to the previous movement. Then, focus was moved parallel to the last movement 
along width in the opposite direction and moved by a line separation. These movements 
were repeated until the sum of the moving distance along the line separation became 
equal to the length, another predetermined channel dimension. Then, the focus was 
moved up along Z by a layer separation and the scanning started over another layer in the 
opposite direction to the previous layer. The scanning stopped before the top surface of 
channel reached the anterior surface of the sclera to preserve the layer between these two 
surfaces. After finishing the creation of the partial thickness drainage channel, the eye 
was reconnected to the outflow measurement setup. The outflow rate was measured 
following the outflow measurement protocol described above. Then, the shape of channel 
was monitored with OCT image to evaluate the efficiency of channel creation.  
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The above procedure was repeated on 3 eyes, creating the channels in different 
dimensions, 800µm (width) × 320µm (length), 800µm (width) × 240µm (length) and 
800µm (width) × 180µm (length), to demonstrate the effect of channel dimensions on the 
amount of the increased outflow rate. 
 
2.3. Results 
Figure 2.6 shows that a partial thickness drainage channel was created at the angle 
of the iris and cornea as bordered by yellow line. It can be seen that the scan was made so 
that the thin layer was remained between the top of channel and the surface of the sclera.  
Experimental data were obtained from 3 enucleated rabbit eyes to compare the 
effects of channel with different dimensions, 800µm (width) × 320µm (length), 800µm 
(width) × 240µm (length) and 800µm (width) × 180µm (length), corresponding to cross 
sectional areas of 0.144, 0.192 and 0.256 mm2. In each eye, the channel was created 
following the same procedure in the same parameters except the dimensions, width and 
length, of the eye.  
As it can be seen in Figure 2.7, the outflow rate was increased in every eye, 
demonstrating the outflow increasing effect of the channel. In addition to this, it is 
obvious that the amount of the increased outflow rate after the laser treatment is increased 
in a positive relation with the width of the channel, indicating that the amount of the 
increased outflow rate can be controlled by adjusting the dimension of channel. This 
increase is considerably larger than any washout effect measured in cadaver eye 
perfusion experiments in various species [9] and in the eyes of in vivo rabbits [10]. 
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Therefore, it can be concluded that most of the outflow rate increasing effect is from the 
subsurface channel.      
 
2.4. Discussion 
It was demonstrated that the subsurface channel can be created by a femtosecond 
laser [7]. However, the subsurface channel must be created at the optimal position in the 
sclera of the eye to show the potential of a femtosecond laser as a laser for the eye 
treatment. Therefore, the first goal of this study is to demonstrate that the subsurface 
channel can be created at the designated position in the sclera of ex vivo rabbit eye for the 
treatment, because the channel was created in the piece of dehydrated sclera in the 
previous study [7].  
Another goal of this study is to demonstrate the outflow rate increasing effect and 
the potnetial of the subsurface channel that the outflow rate increase can be controlled by 
the channel dimensions, because, assuming the IOP increase by the increased outflow 
resistance, the controllable outflow rate increase means that IOP can be controlled to be 
reduced into the normal range. Figure 2.8 shows the increased outflow rate at 25 mmHg 
over the channel dimensions to mimic elevated IOP in glaucomatous eyes, demonstrating 
the potential of the control of reduced IOP by adjusting the channel dimensions.  
OCT was used to monitor the location and shape of channel, because it is 
advantageous to see the intact channel. There are other methods that can monitor the 
section of tissue by slicing it after the fixation. However, our experiment focused on the 
shape of channel remaining only 10 % of sclera thickness and it is very significant to save 
the shape of channel that is difficult to save by the tissue cutting methods. The existing 
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methods that fix the tissue are efficient in saving the overall shape of the tissue. However, 
taking into account the remaining layer of 10% of the original thickness, the subsurface 
tissue can’t be fixed strong enough to save the shape of channel through the cutting 
process. The reliability of the subsurface image of OCT might be questioned, because it 
is a subsurface channel. However, the thickness of sclera is less than 0.5 mm [11] and, 
taking into account the papers on the reliability of OCT images of the intraocular 
structure [12 - 14], it can be concluded that the OCT image is reliable enough to provide 
the valuable monitoring information on the shape and location of channel.  
 This experiment indicates that a femtosecond laser treatment has high potential to 
decrease IOP under in vivo rabbit eyes. To prove this, we conducted in vivo rabbit 
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Figure 2.7. Outflow rate increase in each eye with channel in different dimension (µm) ((a) 800 × 
180, (b) 800 × 240, (c) 800 × 320).  
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FINITE ELEMENT MODEL TO PREDICT IOP REDUCED BY A 




The purpose of glaucoma treatment is to reduce the elevated IOP, but if IOP is not 
reduced into the normal range, the continuous treatment is needed until the reduced IOP 
reaches the normal range. Therefore, the initiate treatment is significant so that IOP can 
be reduced into the normal range quickly. The first step should be to predict the exact 
result of the treatment. Especially for the surgical treatment, it is expected that the 
mathematical model has the potential to not only predict the reduced IOP but propose the 
optimal treatment.  
There have been a number of efforts to model AH dynamics [1-3], but most have 
focused on qualitative aspects of AH flow patterns [2] or the relationship between IOP 
and changes in ocular structures [1, 3].  They have also relied on 2D models, without 
comparison to experimental data. There have been efforts to model the permeability of 
the sclera [4]. However, they focused on the model of piece of sclera, not under ex vivo or 
in vivo condition of the entire eye globe and AH production and drainage system that can 
predict the actual IOP. In contrast to these studies, 3D mathematical model for AH flow 
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in the rabbit eye was constructed that has the potential to predict IOP compared to the 
proper experimental data. In this chapter, the process of developing 2D model into 3D 
model will be described and it will be assessed the feasibility of predicting IOP with a 3D 
mathematical model and its potential use as a tool in predetermining the dimensions of 
the partial thickness channel to reduce IOP predictably in glaucoma management. 
 
3.2. Basic Assumptions 
A 2D finite element model was developed and expanded to 3D model to simulate 
the AH flow dynamics in rabbit eyes based on the following assumptions: 
1. The amount of AH flowing out of the rabbit eye through the uveoscleral pathway is 
not exactly known and the uveosceral flow is not changed over increased IOP [5]. 
Therefore, it is assumed that all the AH outflow occurs through the trabecular 
pathway.   
2. There is no available episcleral vein in ex vivo cadaver rabbit eye. Therefore, it is 
assumed that AH flows through the limbus, the intermediated zone between corneal 
and sclera, to below the conjunctiva. 
3. The trabecular pathway in the rabbit eye is porous, so that outflow through the 
pathway follows the Brinkman equation and its resistance to the outflow can be 
characterized with permeability in the equation. This assumption is in line with the 
efforts to quantify the outflow resistance [2], and ultimately to provide the prediction 
of the decrease in IOP.  
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4. The resistance of pathway is characterized with one comprehensive permeability 
value rather than a summation of the permeability of each component of the pathway.  
5. The structures of the eye such as the cornea are rigid materials, and it is assumed that 
all structural components such as lens and iris inside the eye do not move with 
changes in IOP. The relationship between IOP and movement of eye structures has 
been investigated [1], but it is not the focus of the current study.  
6. The potential impact of temperature and circulatory perfusion on the AH outflow was 
not considered. It was assumed that the fluid flowing into the eye from the reservoir 
as well as the eye is equilibrated to room temperature. Previous studies demonstrated 
[2] that there are two potential heat sources that can have impact on AH flow, the 
temperature difference between the cornea and the rest of the eye and temperature 
differences created by the blood flow. These temperature gradients can affect the 
pattern of AH flow, but its effect on IOP and the increased flow rate through the 
channel is expected to be ignorable. 
 
3.3. Geometry of Model 
The overall dynamics of AH dynamics in rabbit eye is very similar to the human 
eye in that it is secreted from ciliary body and exits the eye in the same pathway as 
humans except the absence of Schlemm’s canal, scleral spur [2, 6]. These are structural 
differences inside the pathway that can be ignored in modeling based on the assumptions 
proposed in the previous section. Therefore, basic 2D model could be constructed, as 
shown in Figure 3.1, so that it focused on AH flow dynamics [7] in the anterior chamber. 
It was shown that the gap between the lens and iris is on the order of micrometers [3, 8]. 
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This very narrow gap is difficult to mesh and even if it is meshed, it cannot be calculated 
with reliable convergence and stability, especially in the 3D model without the use of a 
supercomputer. Therefore, our model focused on AH dynamics after it entered the 
anterior chamber, passing by the gap. The anterior chamber was modeled as a hemisphere 
with a diameter of 12mm along the edge of the iris [2]. The height of the trabecular 
meshwork, the length from the edge of iris to the Schwalbe’s line, in human eyes ranges 
from 0.38 mm to 0.86 mm and the average is 0.65 mm [9]. Therefore, the trabecular 
meshwork (TM) in rabbit eye was assumed to have a height of 0.45 mm, lower than 
human eye. In order to simplify the model, the AH inflow was assumed to enter anterior 
chamber through the velocity inlet marked with a red line in Figure 3.1. Similar 
simplification approaches to model AH in the anterior chamber has been qualitatively 
tried [2]. The 3D model was developed by the revolution of the modified axially 
symmetric 2D model by 360o. The geometry of 3D model with the femtosecond laser 
created channel (marked with a circle) is shown in Figure 3.2.  
The channel was created in the 3D model so that the remaining layer between the 
top of channel and anterior surface of sclera is thin, as described in Figure 3.3(b), but it 
still provides some resistance, characterized with the modified permeability to be referred 
to as “effective channel permeability”, to the outflow.     
 
3.4. Governing Equations and Boundary Conditions  
The Navier-Stokes equation governing AH flow in the anterior chamber and the 
continuity equation are presented as [10],  
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This model is on the AH flow in the steady state and the equations can be modified to the 
following, 
( )( )[ ] 0=∇+∇+∇⋅∇−∇⋅ PTuuuu ηρ                                                                        (3) 
0=⋅∇ u                                                                                                                             (4) 
The AH flow through trabecular meshwork that can be modeled as a porous media is 
governed by Brinkman equation, 
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This equation also can be modified for the steady state flow to  







η PT                                                                              (7) 
0=⋅∇ u                                                                                                                                                       (8) 
where u is velocity (m/s), ρ is density (kg/m3), η is dynamic viscosity (Pa · s), F is 
volume force, P is pressure and κ is permeability (m2). Each equation was modified, 
because we focused on the steady state flow in anterior chamber to get the permeability 
and the volume force is not included. In Brinkman equation, the effect of inertial loss 
 70
term, the first tem of equation (7), is expected to be ignorable, considering the velocity of 
the AH flow in µl / min. However, this term was included in effort to integrate the whole 
effect. The properties of AH used in model were ρ = 1000 kg/m3, η= 1.002 × 10-3 Pa ·s. 
The permeability of pathway is calculated by fitting the experimental AH outflow data 
measured in untreated enucleated rabbit eyes introduced in Chapter 2 to the 2D model.    
Boundary conditions at velocity inlet were given so that the inflow rate was the 
same as the one measured in the experiment of Chapter 2. This eliminates the problems 
from meshing the narrow iris-lens gap. (see Figure 3.1 and 3.4). In the eye of in vivo 
rabbit, AH flows into episcleral vein to exit the eye. Therefore, the final destination of 
AH flow should be modeled to be the constant pressure boundary condition, 9.6 mmHg, 
the pressure in the episcleral vein [11]. However, there is no available blood pressure in 
the episcleral vein in cadaver eyes and the boundary condition was given as atmospheric 
pressure based on the basic assumption 2 and additional assumption that the pressure 
difference between the posterior surface of conjunctiva and the air should be ignorable.  
 
3.5. Numerical Methodology 
Finite element mesh were generated for 2D as shown in Figure 3.4 and refined 
until the IOP value became independent of meshes. The velocity was assigned to the red 
marked line in Figure 3.1 so that the inflow over that line is equal to the inflow rate 
before the laser treatment at 25 mmHg in each eye from the experiment data from 
Chapter 2. The different permeability values of trabecualr pathway were continuously 
fitted until 25 mmHg IOP were calculated.  
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3D model was developed to simulate the AH flow in the eye with a femtosecond 
laser created channel. A huge number of meshes are needed to develop complete 3D 
model for AH fluid in the anterior chamber and it takes the huge computational ability 
such as supercomputer or workstation to calculate the equations. There was no available 
access to computational equipment. Therefore, 3D model was developed in the way that 
can get the utmost out of the available computation capacity. Geometry of 3D model was 
developed, as shown in Figure 3.2, meshed and the same boundary condition was given 
as 2D model.  
The governing equations were discretized and solved by COMSOL Multiphysics 
3.4. Equations were solved by an affine invariant form of the damped Newton method 
[10]. In each Newton step, GMRES method was used with incomplete LU preconditioner.  
 
3.6. Calculation Procedure 
AH should be simulated in 3D model and the permeability values of pathways 
should be known to predict the effect of the subscleral drainage channel on IOP. 
Therefore, the overall calculation was processed in the following order.  
3.6.1. Calculation of Permeability Values of Untreated Pathway in 2D Model 
The inflow rates in the untreated eyes before the laser treatment were assigned 
into 2D model to calculate the permeability values of the untreated pathway by 
continuously fitting the different values until IOP was calculated to be 25 mmHg.  
3.6.2. Verification of the Model Expansion to 3D 
The 2D model was expanded to 3D by the revolution by 360 degree. The ideal 
model expansion is to simulate AH in 3D model in the same flow pattern and IOP as in 
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2D model under the same input and boundary conditions. The flow pattern and IOP 
values in 3D model were compared to those in 2D model to verify the reliability of 
expanded 3D model.    
3.6.3. Calculation of Permeability of the Remaining Layer  
The permeability of the remaining layer between the top of channel and the 
anterior surface of sclera was calculated by continuously fitting the permeability values to 
the layer under the calculated permeability values of untreated pathway and boundary 
conditions from the experimental data of the post-treatment outflow rate until IOP was 
calculated to be 25 mmHg in each eye. 
 
3.7. Results  
AH flow in the intact was simulated by 2D model as shown in Figure 3.5 in the 
same pattern as predicted in other papers [3], qualitatively verifying the model. 
Permeability values of the trabecular meshwork  in 2D model were calculated to be 1.34 
× 10-14,  1.28 × 10-14,  1.25 × 10-14 m2  in the ascending order of channel dimensions of 
800 µm × 180 µm, 800 µm × 240 µm and 800 µm × 320 µm, corresponding to cross 
sectional areas of 0.144, 0.192 and 0.256 mm2. 
The agreement with 2D model was 95 %, 96 %, 98 % and the flow pattern in 3D 
was predicted in the same pattern as in 2D model as described in Figure 3.6. Figure 3.7 
also shows the flow through the channel. Considering the ultimate goal of the model is to 
predict IOP based on the provided information, the outflow rate, it can be concluded that 
the reliable value of IOP can be predicted by 3D model.   
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The effective channel permeability of each eye was calculated to be 3.2 × 10-13 m2, 
4.35 × 10-13 m2 and 5.15 × 10-13 m2  in the ascending order of channel dimensions.  
 
3.8. Discussion 
The goal of this modeling is to demonstrate the potential of 3D FEM model as a 
tool that can predict the reduced IOP by simulating AH. Modeling the outflow in 
enucleated cadaver eyes provided challenge for this study. Since there is no blood flow in 
the episcleral vein, the boundary condition for final destination of AH could not be used 
in the model. To describe outflow in the enucleated rabbit eyes, we assumed that AH 
flows through the pathway to the posterior surface of the conjunctiva, therefore boundary 
conditions were set to the atmospheric pressure rather than the episcleral vein pressure. 
However, this is reasonable assumption, because, taking into account the location of the 
episcleral vein just below the conjnuctiva [11] and porosity of the remaining layer 
beyond the episcleral vein, it can be expected that AH would continuously flow beyond 
the episcleral vein. 
Uveoscleral flow was neglected in the model, because its exact flow rate is not 
known and its contribution to the total outflow is reduced as IOP is increased as 
mentioned in introduction [12]. This assumption is not expected to result in considerable 
errors in the model as we focused on modeling the effect of the partial thickness drainage 
channel on the outflow dynamics through the trabecular pathway.  
The effect of partial thickness drainage channel was modeled by assigning 
appropriate permeability value for the remaining thin scleral layer at the anterior end of 
the channel. It could be shown that the amount of increased outflow rate is in positive 
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relation with the permeability values of the effective channel permeability. It means that 
the amount of IOP reduction is affected also by the value of the effective channel 
permeability. Therefore, it can be concluded that it is necessary to know the value of the 
effective channel permeability to predict IOP. The effective channel permeability should 
have the thickness dependent value and it can be calculated by creating very small 
channel with the thickness that the actual channel will have and inputting the amount of 
IOP reduction by this small channel, the measured inflow rate into the model developed 
in this study. Then, IOP can be predicted by 3D model and the optimal dimension of 
channel can be proposed to reduce IOP as much as needed.  
Necessity of 3D Model 
There might be the potential question on the need or necessity of 3D model to predict 
IOP if the channel effective channel permeability defines IOP reducing efficiency of 
channel. The necessity of channel can be demonstrated by introducing the factor of safety 
(FOS) used in design [13]. If FOS is 1, it means the design is optimized just as much as 
needed. Applying this concept to this treatment, if channel is created just in the calculated 
dimensions, it means that the channel has been created based on the assumption of no 
change in the properties of the eye and excluding any unexpected accident on the eye. 
Therefore, the possible unexpected changes such as additional IOP elevation or impact to 
the eye should be taken into account when the dimension and location of channel are 
decided. In this study, the channel was created so that only thin layer was remained to 
magnify the effect. However, if this treatment is employed in the clinical purpose, the 
location and dimension of channel should be determined so that the treatment must be 
able to stand against unexpected changes. One of the possible ways is to adjust the 
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channel dimensions by increasing the thickness of the remaining layer. Its effect can be 
made up by increasing width and length or creating multiple channels can be another way. 
In these cases, the necessity of 3D model can be demonstrated by investigating the 
change of ratio of the flow through the top surface of channel, described in Figure 3.3(b) 
and 3.7(b), to whole outflow over different depth. 
Figure 3.8 shows that the ratio of the flow through the top surface of channel is 
decreased with the increase of the thickness of the remaining layer. It means the effect of 
the flow through the trabecular pathway excluding the remaining layer is increased. 
Ultimately, it demonstrates the necessity of 3D model to predict IOP, taking into account 























































Figure 3.3. Details of 3D model corresponding to (a) Subsurface channel (highlighted with red) 
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Figure 3.8. The flow rate through the remaining top layer of the channels as a function of the 
channel dimensions when thickness of the top layer is 11.5% of the toteal scleral thickness (blue 
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4.1.  Introduction 
It was demonstrated in Chapter 2 that a femtosecond laser created subsurface 
scleral channel in ex vivo rabbit eye increases the AH outflow leading to the IOP 
reduction. However, this was only qualitative assessment of the feasibility of IOP 
reduction by subsurface scleral channel, since the elevated IOP was mimicked by 
increasing the inflow into the anterior chamber and the effect was demonstrated by the 
increased outflow. Therefore, it is necessary to show the effect of subsurface scleral 
channels on the IOP under in vivo condition to demonstrate the actual effect that can be 
expected in the clinical study. It is also necessary to refine the experimental setup, 
because the scanning under in vivo condition can not be made by moving the object as it 
was possible in the ex vivo experiment.  
In this chapter, the refined experimental setup will be shown to make scan by 
moving the focus. It will be assessed if the subsurface scleral channel can be created in
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the eyes of in vivo rabbits as in ex vivo experiment. The effect of channel will be 
evaluated in the way that it is actually evaluated in the clinic. The important 
consequences will be discussed for the analysis of the results from in vivo experiment.   
 
4.2. Methods 
4.2.1. Experimental Setup 
The laser delivery system introduced in Chapter 2 was used in this experiment. 
The scanning mechanism was altered to move the beam focus to scan the femtosecond 
laser pulses into the eye of in vivo rabbits as described in Figure 4.1 to Figure 4.2. 
Comprehensive scanning experiment was setup as shown in Figure 4.1. The rabbit holder 
was mounted on an adjustable stage so that the eye could be targeted at the optimal 
position for the laser treatment. A microscope slide was placed on the top of the eye by 
the means of a slide holder, avoiding the pressure on the eye, so that scattering at the 
scleral surface could be minimized. The laser beam was reflected by a mirror and 
propagated through the 0.5 NA focusing objective so that the focused beam passed down 
into the eye in normal direction to the surface of microscope slide as shown in Figure 4.1 
and 4.2. The X, Y and Z axes were set up as described in Figure 4.2 in the same way as in 
Chapter 2. The difference from ex vivo experiment setup is that the aspheric lens was 
attached to the stage, as shown in Figure 4.2 controlled by the computer so that the focus 
can be moved in the predetermined pattern as shown in Chapter 2.  
4.2.2. Experimental Procedure 
New Zealand albino rabbit was anesthetized with ketamine and xylazine. IOP was 
measured 10 times with tonopen (Reichert Analytical Instrument; Depew, NY). Rabbit 
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was fixed in the holder, as shown in Figure 4.1 and the eye was located at the optimal 
position so that the limbus was on the propagation axis of laser beam. The microscope 
slide was placed on the eye where the channel needed to be created, maintaining the 
surface normal to the propagation axis of laser beam. 
The position of the focusing lens was adjusted along Z axis so that the focus of 
laser beam was located at the angle of the eye as marked by red arrow in Figure 4.3. 
The focusing lens was located inside the expanded laser beam so that it could keep 
focused with irradiance higher than optical breakdown threshold for sclera during whole 
scanning process. The energy of laser beam was set to be 18 µJ. Scanning parameters 
were set to be a 2 µm spot separation, a 4 µm line separation and a 2 µm layer 
separation. The scanning was made in the same way as in ex vivo experiment introduced 
in Chapter 2 except that the lens was moved. 
IOP values were measured 10 times after the laser treatment to evaluate the IOP 
reducing effect of channel. After the IOP measurement, the shape of channel was 
monitored with OCT image as shown in Figure 4.4 [1] to evaluate the efficiency of 
channel creation. Mean value over 10 measurements was used to evaluate IOP changes. 
 
4.3. Results 
One channel was created in each of four rabbits at the angle of the eye through 
the trabecular pathway as shown in OCT images of Figure 4.4 [1]. Dimensions of 
channel, width × length, were 450µm × 150µm, 600µm ×200µm, 600µm × 220µm and 
800µm × 240µm, corresponding to cross sectional areas of 0.068, 0.12, 0.132 and 0.192 
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mm2. As shown in Figure 4.4, the channel was created, remaining the thin layer 
between the top of channel and the anterior surface of sclera. 
The channel in the eye imaged by the confocal microscope (see Figure 4.5) was 
scanned with the same parameters as the eye shown in Figure 4.4. It can be seen in 
Figure 4.5 that the thin layer on the top of the channel remained intact in the same way 
as in the eye shown on the OCT image in Figure 4.4, but the shape of channel is 
different from that shown in Figure 4.4. This difference is believed to be from the 
postmortem change in the sclera to be addressed in discussion section.  
The effect of channel can be evaluated by the amount of reduced IOP, the 
difference in IOP values measured before and after the laser treatment. Figure 4.6 
shows pre-treatment IOP value and the amount of reduced IOP over different channel 
dimensions. However, the amount of IOP reduction is affected by pre-treatment IOP 
value, because higher IOP induces higher outflow rate increase through channel, 
leading to higher levels of IOP reduction.   
Therefore, the IOP reduction was normalized by the pre-treatment IOP value for 
the comprehensive evaluation of the channel effect as shown in Figure 4.7. It can be 
seen that the percentage based IOP reducing effect increases over the dimension of 
channel in a positive relation from 15 % to 48 %, indicating that the channel dimension 
has the dominant effect.  
 
4.4. Discussion 
The goal of this experiment was to demonstrate that the subsurface scleral 
channel with IOP reducing effect can be created in the eyes of in vivo rabbits. In the ex 
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vivo experiment described in Chapter 2, the effect of channel was demonstrated by the 
post-treatment outflow rate increased up to three to four times of the pre-treatment 
outflow because the experimental setup was designed to mimic the elevated IOP in 
glaucomatous eye so that the maximum amount of AH would flow through the 
remaining layer between the surface of sclera and the top of channel. Since the pressure 
in the eye was maintained by connecting the pressurized water reservoir to the eye, IOP 
reduction cannot be demonstrated in the perfusion experiments.   
In addition to this, it is also obvious in Figure 4.7 that the IOP reduction of 
channel has a positive relation with dimensions of channel, proposing the strong 
potential of controlling the IOP reduction by adjusting channel dimensions. Therefore, 
it can be concluded that the disadvantages of current glaucoma treatment, such as 
infection and difficulty in controlling the value of post-treatment IOP, may be 
significantly improved with the femtosecond klaser treatments. The limited longevity of 
usage, the major disadvantage of LT, is expected to be reduced also, because it is 
expected that the effect of subscleral channel would last longer than scratch or widened 
hole by LT. 
The shape of channel before and after the sacrifice of a rabbit can be 
reconstructed with lines based on Figure 4.4 and 4.5 as shown in Figure 4.8. The 
channel shape in Figure 4.4 can be explained by the existence of force by IOP, red 
arrows in Figure 4.8(a). The channel shape in Figure 4.5 can be reconstructed as Figure 
4.8(b). The difference in the shape of channel can be explained by the postmortem 
change in the sclera and the absence of IOP. As it was mentioned in Chapter 1, the 
sclera maintains the shape of the eye with its rigidity [2], indicating that the balance 
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between the sclera rigidity and IOP maintains the shape of the eye. Under in vivo 
condition, the channel is created in the existence of IOP. Therefore, once the channel is 
created, the IOP inside the channel maintains the shape of channel as described in 
Figure 4.8 (a).  
However, IOP is reduced significantly and the rigidity of sclera is changed after 
the rabbit is sacrificed. In addition to this, the rigidity and the force on sclera by IOP 
can not be uniform over the sclera, indicating the possible different postmortem changes 
depending on the position in the sclera. This also demonstrates the advantage of 
monitoring the shape of channel by OCT that can show the intact shape of channel 
under in vivo condition. 
IOP was measured by the commercial tonopen (Reichert Analytical Instruments; 
Depew, NY). Tonopen is so reliable as it is used in clinic [3] and IOP values measured 
in this study is also reliable. Therefore, it can be concluded that it is very likely that this 
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Figure 4.8. The shape of channel before and after the sacrifice ((a) Predicted channel shape under 
in vivo condition based on OCT image with red arrowed IOP, (b) Distorted channel shape due to 
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CONCLUSIONS AND FUTURE STUDIES 
  
 
5.1. Summaries and Contribution of Dissertation 
Since advantageous properties of a femtosecond laser were found, various 
potential applications of femtosecond laser pulses have been proposed. The work in this 
dissertation materialized the non-invasive surgical procedure significantly reducing the 
disadvantages limiting the efficiency of currently used treatments. Additionally, the 
potential of a tool supporting the procedure was proposed. The contribution of the works 
in this dissertation can be summarized by each chapter like the following:  
  In Chapter 2, the experiment was conducted on ex vivo rabbit to create the 
subsurface scleral channel as a first step to assess the feasibility of potential of a 
subscleral channel as a treatment for glaucoma. The contribution made by this 
experimental work can be listed as following; 
1. The demonstration of the feasibility that the subsurface scleral channel can be 
created with femtosecond pulses in the eye through the trabecular pathway. 
2.  The demonstration of AH outflow increasing effect of channel that can be 
controlled by adjusting the dimensions of channel. 
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3. The demonstration of advantageous property of treatment by a femtsecond laser 
that can leave the surface sclera intact without any damage to the neighboring 
tissues inducing scar and infection. 
In Chapter 3, 3D finite element model was developed. The goal of glaucoma 
treatment is to continuously manage IOP within the normal range and a tool that can 
predict IOP is needed to determine the details of treatment such as dimensions and 
location of channel. The modeling work contributed to demonstrating the potential of the 
following: 
1. 3D FEM model to predict the reduced IOP and propose the optimal treatment. 
2. The new methodology to quantify the effect of the channel by the permeability of 
the remaining layer. 
In Chapter 4, the experiment was performed on the eyes of in vivo rabbits to 
create the channels in different dimensions. It was demonstrated that the subsurface 
channel could be created with the altered experimental setup by moving the focus to 
make a scan. This in vivo experimental study made the following contributions: 
1. The demonstration of the creation of subsurface channel by a femtosecond pulse 
and its IOP reducing effect under in vivo condition very similar to the clinical 
study. 
2. The proposition of the strong potential that the reduced IOP can be controlled 
under in vivo condition. 
3. The proof of the effect of postmortem change in scleral tissue on the shape of 
channel. This result will provide the valuable guide for the analysis of 
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experimental result, taking into account the postmortem change and the prediction 
of in vivo result from ex vivo experiment.   
 
5.2. List of Publications 
The following contributions were made during the works for this dissertation. 
1. D. Chai, G. Chaudhary, R. M. Kurtz, and T. Juhasz, “Aqueous humor outflow 
effects of partial thickness channel in ex vivo eyes,” Proceedings of SPIE, vol. 
6426, pp. 64350O, 2007. 
2. D. Chai, G. Chaudhary, E. Mikula, H. Sun, and T. Juhasz, “3D finite element 
model of aqueous humor to predict the effect of femtosecond laser created partial 
thickness channels on the IOP,” ASLMS: American Society for Laser Medicine 
and Surgery, Grapevine, Texas, April 2007. 
3. D. Chai, G. Chaudhary, E. Mikula, H. Sun, and T. Juhasz, “Modeling the effect of 
femtosecond laser created intrascleral channel in rabbit eye,” ARVO: The 
Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 
May 6-10, 2007. 
4. D. Chai, G. Chaudhary, E. Mikula, H. Sun, R. M. Kurtz, and T. Juhasz, “In vivo 
creation of subscleral channel in rabbit eye with femtosecond laser”. ARVO: The 
Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 
April 27 - May1, 2008. 
5. D. Chai, G. Chaudhary, E. Mikula, H. Sun, and T. Juhasz, “3D finite element 
model of aqueous outflow response to femtosecond laser glaucoma treatments,” 
Lasers in Surgery and Medicine, vol. 40, pp. 188-195, 2008. 
 103
6. D. Chai, Chaudhary. G, Mikula. E, Sun. H, R. Rurtz, and Juhasz. T, “IOP 
reduction after femtosecond laser subsurface scleral treatments in the eyes of in 
vivo rabbits,” submitted to Journal of Glaucoma, 2008. 
 
5.3. Direction of Future Studies 
5.3.1. The Refinement of the Experimental Setup for the Creation of Channel 
through the Trabecular Pathway 
Figure 5.1 and 5.2 show the procedural differences between cornea treatment and 
sclera treatment. It can be seen that a more refined experimental setup that can move and 
rotate the head to locate the eye at the proper angle for the treatment is needed for 
treatment through the sclera. As described in Figure 5.1, the cornea treatment does not 
use detailed positioning equipment due to the following reasons: 1) cornea is transparent 
and most protruding part of the eye, 2) the methodology of cornea treatment is to create a 
flap by making a cut in the cornea. However, as described in Figure 5.2, the equipment 
for detailed positioning is needed in the channel creating laser treatment through sclera in 
this study for the following reasons: 1) the sclera is translucent, 2) the channel is created 
by scanning the eye from the bottom of the translucent sclera and through the designated 
route, the trabecular pathway. Figure 5.3 shows that, even though scanning begins at the 
same position, channels with different effects can be created depending on the angle of 
the beam. Therefore, an experiment setup that can adjust the position and angle of the eye 
is needed for more advanced treatment with consistent success. 
5.3.2. The Equipment for more Effective and Exact Evaluation of Treatment 
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The channels created in this study are subsurface ones and the shape, dimension 
and location of channel are critical. Therefore, efficient monitoring of the intact channel 
is essential to determine the optimal treatment procedure. Image of intact channel under 
in vivo condition can not be obtained with the conventional microscope image, because 
the damages to tissues, causing the changes of shape and location of channel, are 
unavoidable during the processes, such as cutting and fixation, for microscope imaging. 
Therefore, OCT was used in this study for imaging of the channel as it was created under 
in vivo condition. However, as described in Figure. 5.4, even when using OCT equipment 
is needed to locate the eye in the position such that the exact dimension, shape, and 
location of channel can be imaged by OCT at the consistent angle to the scanning 
direction. 
5.3.3. The Optimization of Procedure by the Real-Time Monitoring  
Even though the experimental study on the eyes of the in vivo rabbit was 
successful in this study, the procedure can be optimized by adjusting the scanning 
parameters, beam energy, and starting and ending the scanning the exactly projected 
positions. Then, IOP will be able to be reduced with minimal tissue damage, reducing 
IOP as much as needed. It is most significant to locate the focal point of beam at the 
projected position in the sclera. It cannot be completed with the refined setup mentioned 
in section 5.2.1, as shown in Figure 5.5, because the actual position of focus can not be 
monitored, even though it could be set up at the proper angle. Therefore, the real time 
monitoring system is needed to start the scan at the projected position. Then, the energy 
of the beam can be determined so that it will be slightly higher than the threshold of 
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LIOB. Finally, the scanning can be stopped exactly at the predetermined end position 
leaving a layer with the projected thickness. 
It should be a long term goal to monitor in real time what happens in the sclera. 
Considering the channel is created with laser scanning, OCT has the potential to be 
intuitively incorporated into the existing laser delivery housing, eliminating the need for a 
stand-alone imaging probe. 
5.3.4. The Effect of Wound Healing on the Longevity of Treatment    
 Once the channel is created in the eye of the living animal, it is supposed to be 
healed by the physiological wound healing. Following the wound healing process, it is 
expected that the space of channel will be filled over time, as described in Figure 5.6, and 
the IOP reducing effect of channel will be reduced also. Therefore, it is necessary to 
monitor the wound healing process over time to evaluate the longevity of the treatment 
and, ultimately, develop a follow up treatment that can maintain the IOP reducing effect 
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Figure 5.6. The expected wound healing process over time from (a) intact channel to (b), (c) and 
(d) healed channel over time. 
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